Epidemiological and pathological characteristics of postsurgical cases of invasive breast cancer among ethnicities of Iran in 2018: A single center cross-sectional study

Epidemiological and pathological characteristics of postsurgical cases of invasive breast cancer among ethnicities of Iran in 2018: A single center cross-sectional study

Background: Present study aimed to investigate immunohistochemical parameters in post-surgical cases of invasive breast cancer. Methods: In this single center cross-sectional study we investigated ethnicity, familial history, type of cancer, stage of cancer, lymph node positivity, bilateral involvem...

Full description

Bibliographic Details
Main Authors:	Sayad Soheila, Yasin Ahmadi Seyyed Amir, Nekouian Reza, Panahi Mahshid, Anbari Khatereh
Format:	Article
Language:	English
Published:	Institute of Oncology, Sremska Kamenica, Serbia 2020-01-01
Series:	Archive of Oncology
Subjects:	breast cancer estrogen receptor her2 triple negative pathology iran
Online Access:	https://scindeks-clanci.ceon.rs/data/pdf/0354-7310/2020/0354-73102001006S.pdf

Similar Items

A Comparison of Clinical Features, Pathology and Outcomes in Various Subtypes of Breast Cancer in Indian Women
by: Anupama Mane, et al.
Published: (2015-09-01)

Triple-Negative Breast Cancer: Clinical Characteristics, Prognostic Features, and Long-Term Outcome: A Comparative Study
by: Leila Rahmani, et al.
Published: (2012-03-01)

Triple-Negative Breast Cancer: Clinical Characteristics, Prognostic Features, and Long-Term Outcome: A Comparative Study
by: Tahere Zarouk Ahimahalle, et al.
Published: (2012-01-01)

Low Prevalence of HER2-Positive Breast Carcinomas among Screening Detected Breast Cancers
by: M. Ángeles López-García, et al.
Published: (2020-06-01)

Triple Negative Breast Cancer-An Overview and Review of Literature
by: Amit Gupta
Published: (2013-02-01)

Current approaches in treatment of triple-negative breast cancer
by: Hanan Ahmed Wahba, et al.
Published: (2015-06-01)

Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs
by: Tejaswini P. Reddy, et al.
Published: (2020-05-01)

Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape
by: Garbar C, et al.
Published: (2018-05-01)

Estrogen Receptors, Progesterone Receptors and their Correlation with respect to HER-2/neu Status, Histological Grade, Size of Lesion, Lymph node Metastasis, Lymphovascular Involvement and Age in Breast Cancer patients in a hospital in north India
by: Mushood G. Nabi
Published: (2016-01-01)

Carcinomas invasores triples negativosde la glándula mamaria: incidencia y características clínico-patológicas Triple-Negative Invasive Breast Carcinoma: Incidence and Clinical - Pathological Characteristics
by: José L Quirós-Alpízar, et al.
Published: (2010-06-01)

Triple negative breast cancer: MRI features in comparison to other breast cancer subtypes with correlation to prognostic pathologic factors
by: Noha Mohamed Osman, et al.
Published: (2014-12-01)

Triple-Negative Breast Cancer Survival in Iranian Patients
by: Mahdi Aghili, et al.
Published: (2013-08-01)

Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda
by: Mlole AT, et al.
Published: (2020-11-01)

Pattern of recurrence and survival in TNBC-a retrospective study done in a rural based medical college and hospital of West Bengal India
by: Acharya, S., et al.
Published: (2021)

Age-related Variation in Expression of Breast Cancer Tumour Markers in Iranian Patients
by: Fatemeh Homaei Shandiz, et al.
Published: (2021-04-01)

Prognostic role of GPER/Ezrin in triple-negative breast cancer is associated with menopausal status
by: Shuang Ye, et al.
Published: (2019-05-01)

Lumpectomy followed by radiation improves survival in HER2 positive and triple‐negative breast cancer with high tumor‐infiltrating lymphocytes compared to mastectomy alone
by: Jason A. Mouabbi, et al.
Published: (2021-07-01)

Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers
by: Gabriela Morales-Guadarrama, et al.
Published: (2021-07-01)

Clinical characteristics of triple negative breast cancer in Egyptian women: a hospital-based experience
by: Nivine Gado, et al.
Published: (2016-06-01)

Conferring receptors on recipient cells with extracellular vesicles for targeted drug delivery
by: Zachary Quinn, et al.
Published: (2021-03-01)

Clinicopathologic Features and Survival of Breast Cancer Subtypes in Northeast Iran
by: Soodabeh Shahidsales, et al.
Published: (2018-01-01)

Estrogen Actions in Triple-Negative Breast Cancer
by: Oliver Treeck, et al.
Published: (2020-10-01)

Strong and Sustained Response to Treatment with Carboplatin plus Nab-Paclitaxel in a Patient with Metastatic, Triple-Negative, BRCA1-Positive Breast Cancer
by: Abdur R. Shakir
Published: (2014-04-01)

Estrogen-Related Receptor α (ERRα) and G Protein-Coupled Estrogen Receptor (GPER) Synergistically Indicate Poor Prognosis in Patients with Triple-Negative Breast Cancer
by: Ye S, et al.
Published: (2020-09-01)

Preliminary research on regulatory effect of estrogen on malignant biological behaviors of triple-negative breast cancer cells and its molecular mechanisms
by: Tian-Fang Zhou
Published: (2016-03-01)

Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer
by: Reyhaneh Farghadani, et al.
Published: (2021-07-01)

Atypical glandular cells: Help or hindrance
by: Sanjeev Narang, et al.
Published: (2018-04-01)

Immunohistoochemical evaluation of GATA-3, pAKT and Ki-67 in triple negative breast carcinoma
by: Gopi Aryal, et al.
Published: (2017-09-01)

Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response
by: Sarah Boughdad, et al.
Published: (2020-01-01)

Outcomes After Accelerated Partial Breast Irradiation in Women With Triple Negative Subtype and Other “High Risk” Variables Categorized as Cautionary in The ASTRO Guidelines
by: Anabel Goulding, et al.
Published: (2021-03-01)

Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast Cancer
by: Alberto Montero, et al.
Published: (2012-12-01)

A DNA Repair BRCA1 Estrogen Receptor and Targeted Therapy in Breast Cancer
by: Adisorn Ratanaphan
Published: (2012-11-01)

Molecular basis of the triple negative breast cancer
by: Ayse Feyda Nursal
Published: (2015-06-01)

Radiomic Analysis in Contrast-Enhanced Spectral Mammography for Predicting Breast Cancer Histological Outcome
by: Daniele La Forgia, et al.
Published: (2020-09-01)

Precision medicine in breast cancer: reality or utopia?
by: Ali Bettaieb, et al.
Published: (2017-06-01)

Higher-risk breast cancer in women aged 80 and older: Exploring the effect of treatment on survival
by: Abdulla Al-Rashdan, et al.
Published: (2021-10-01)

Survey of low ER-positive expression and its correlation with other clinical and pathological factors in breast cancer
by: Atena Azami, et al.
Published: (2020-01-01)

Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report from Cancer Institute of Iran
by: Mehrzad Mirzania, et al.
Published: (2016-12-01)

Is software method helpful for detection of angiogenesis in breast tissue slides?
by: Soheila Sayad, et al.
Published: (2019-07-01)

Proteomic analysis identifies highly expressed plasma membrane proteins for detection and therapeutic targeting of specific breast cancer subtypes
by: Yvonne S. Ziegler, et al.
Published: (2018-09-01)